A Meta-Analysis Evaluating the Effectiveness and Safety of Upadacitinib in Treating Rheumatoid Arthritis in Patients With Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs

Upadacitinib, an oral Janus kinase (JAK) inhibitor, is used to manage rheumatoid arthritis. The objective was to generate statistical evidence from the existing data for upadacitinib efficacy and safety in various treatment regimens with different dosages in active rheumatoid arthritis patients. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Panchal, Viraj, Vyas, Bhavya H, Sivasubramanian, Barath Prashanth, Panchal, Kanan, Patel, Harshank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976645/
https://www.ncbi.nlm.nih.gov/pubmed/36874682
http://dx.doi.org/10.7759/cureus.34384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976645/
https://www.ncbi.nlm.nih.gov/pubmed/36874682
http://dx.doi.org/10.7759/cureus.34384

Ejemplares similares